iShares JPMorgan USD Emerging Markets Bond ETF vs Raytheon Technologies Corp — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $91.1 (market cap $12.87B), while Raytheon Technologies Corp trades at $186.23 (market cap $248.42B). The key difference: Raytheon Technologies Corp is far larger — about 19.3× iShares JPMorgan USD Emerging Markets Bond ETF's market cap, and Raytheon Technologies Corp pays a 1.58% dividend while iShares JPMorgan USD Emerging Markets Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares JPMorgan USD Emerging Markets Bond ETF for 50 Days and Raytheon Technologies Corp for 78 Days on average.
| EMB | RTX | |
|---|---|---|
Market Cap | $12.87B | $248.42B |
Volume | 14,946,002 | 4,380,368 |
Sector | Fixed Income | Industrials |
52-Week High | $97.74 | $225.49 |
52-Week Low | $90.14 | $157.00 |
Typical Hold Time | 50 Days | 78 Days |
Enterprise Value | — | $278.97B |
Dividend Yield | — | 1.58% |
Signals from Pluang's Aura AI — not financial advice
EMB trades at $90.96 with minimal daily movement (+0.2%), showing technical bearish signals from moving averages while oscillators remain neutral. The stock faces resistance at $91-92 with support at $90. Recent dividend declarations of $0.41-0.44 per share provide income appeal, though key financial ratios remain undisclosed in current data.
The outlook appears cautious with technical indicators signaling bearish momentum. Income-focused investors may find value in the dividend yield, but limited fundamental data availability and bearish technical signals suggest careful evaluation is warranted. Market risks include broader economic pressures affecting bond yields and emerging market exposure.
RTX trades at $180.26, down 1.65% today, amid a bearish technical signal but strong fundamental performance. The company reported three consecutive quarterly earnings beats, with Q3 2026 EPS expected at $1.77. Revenue grew to $88.6B in 2025, with net income margin improving to 7.59%. Analyst consensus remains strongly bullish with a $236.27 price target and 65% buy ratings, supported by a $289B backlog and defense sector tailwinds.
The outlook for RTX is positive given robust defense spending, earnings momentum, and analyst confidence. Risks include execution on large contracts, debt levels, and geopolitical uncertainties. The stock offers growth potential with a 30% upside to consensus target, but investors should monitor quarterly execution and defense budget developments.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.
Read more on RTX →